WHO gives AstraZeneca-Oxford's COVID-19 vaccines emergency use approval
WHO gives AstraZeneca-Oxford's COVID-19 vaccines emergency use approval
Share:

Many countries have started their vaccination drive against corona. Many vaccine recieved approval for the use.  In an another approval, The World Health Organisation (WHO) on Monday  approved two versions of AstraZeneca-Oxford-developed COVID-19 vaccines for emergency approval. 

At the daily press briefing, Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said, "Today, WHO gave emergency use listing to two versions of the Oxford-AstraZeneca vaccine, giving the green light for these vaccines to be rolled out globally through COVAX." According to the report, The vaccines are being produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India. WHO's EUL assesses the quality, safety and efficacy of corona vaccines. It also allows countries to expedite their own regulatory approval to import and administer corona vaccines. 

Ghebreyesus further said that the listing was completed in just under four weeks from the time WHO received the full dossiers from the manufacturers. Highlighting that the number of reported cases of COVID-19 globally has now declined for the fifth consecutive week, he said that "the fire is not out". He also said that the number of reported cases of COVID-19 globally has now declined for the fifth consecutive week. Last week saw the lowest number of reported weekly cases since October. What matters now is how we respond to this trend. The fire is not out, but we have reduced its size. If we stop fighting it on any front, it will come roaring back."

Also Read: 

China tries to eradicate Dalai Lama from Tibetans' religious lives

WTO appoints Ngozi Okonjo-Iweala as new director-general

Zimbabwe receives its batch-1 of COVID-19 vaccines from China

 

Join NewsTrack Whatsapp group
Related News